RDHL RedHill Biopharma Ltd.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in ad…
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Older | ||
 RedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties? RedHill Biopharma Ltd. (NASDAQ:RDHL) acquired exclusive global commercialization rights to Rebyota and exclusive U.S. commercialization rights to Clenpiq from Ferring Pharmaceuticals. The agreement has an initial 13-year term and automatically renews for successive two-year periods unless either party elects not to renew. RedHill Biopharma Ltd. (NASDAQ:RDHL) paid $12 million upfront, funded from the $18 million […] | ||
 Redhill Biopharma Stock Doubles In One Session — Here's Why Redhill Biopharma Ltd. (NASDAQ:RDHL) shares are up on Monday as investors react to the company’s divestment of Talicia and the cash-and-milestones structure tied to that deal. RDHL Stock Jumps After Talicia Divestment To Apotex Redhill says it is divesting Talicia to Apotex for $18 million in upfront cash plus additional milestone payments, framing the move as a key step in its strategic roadmap to reposition its commercial business toward larger product opportunities and revenue growth. Read Al | ||